Mineralys Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $21.46-$47.65 |
Market Cap | $1.9B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.22 |
News
See moreYahoo Finance • 3 months ago
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
Yahoo Finance • 3 months ago
What to Know About This Mineralys Insider Sale Before a December FDA Date
Yahoo Finance • 4 months ago
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Yahoo Finance • 4 months ago
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
About
CEO | Dr. Jon Congleton |
CFO | Mr. Adam Scott Levy |
Address | 150 N. Radnor Chester Road, Radnor, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |